VERA Q1 2023 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$506,000

Operating Income

-$31M

Net Income

-$30M

EPS (Diluted)

$-0.79

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$210M

Total Liabilities

$52M

Stockholders' Equity

$158M

Cash & Equivalents

$137M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$506,000	$0	—
Operating Income	-$31M	-$17M	-83.6%
Net Income	-$30M	-$17M	-76.0%